NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Trade Payables | ₹79 Cr | ₹43 Cr | ₹28 Cr | ₹43 Cr | ₹28 Cr |
What is the latest Trade Payables ratio of NATH BIOGENES (INDIA) ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹79 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹28 Cr |
| Mar2022 | ₹43 Cr |
| Mar2013 | ₹28 Cr |
How is Trade Payables of NATH BIOGENES (INDIA) Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹79 Cr | 83.58 | |
| Mar2024 | ₹43 Cr | 56.10 | |
| Mar2023 | ₹28 Cr | -35.17 | |
| Mar2022 | ₹43 Cr | 54.93 | |
| Mar2013 | ₹28 Cr | - | |
Compare Trade Payables of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹330.6 Cr | 2.1% | 29.1% | 0.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,556.5 Cr | -1% | 8.5% | -24% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,771.8 Cr | -1.7% | 18.2% | -36.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,248.0 Cr | -0.5% | 30.7% | -12.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,052.6 Cr | -0.6% | 31.1% | -31.4% | Stock Analytics | |
| INDO US BIOTECH | ₹208.5 Cr | -2.8% | 2.5% | -41% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 2.1% |
29.1% |
0.9% |
| SENSEX | -1.6% |
3.7% |
-2.7% |
You may also like the below Video Courses